Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 34 results.
User Information
Export Records
  1. 1.   Overactivation of the NF-?B Pathway Impairs Molar Enamel Formation
  2. Yamada, Akane; Kawasaki, Maiko; Miake, Yasuo; Yamada, Yurie; Blackburn, James; Kawasaki, Kataushige; Trakanant, Supaluk; Nagai, Takahiro; Nihara, Jun; Kudo, Takehisa; Meguro, Fumiya; Schmidt-Ullrich, Ruth; Liu, Bigang; Hu,Yinling; Page, Angustias; Ramírez, Ángel; Sharpe, Paul T; Maeda, Takeyasu; Takagi, Ritsuo; Ohazama, Atsushi
  3. Oral diseases. 2020, JUL 9;
  1. 2.   Integrity of IKK/NF-kappa B Shields Thymic Stroma That Suppresses Susceptibility to Autoimmunity, Fungal Infection, and Carcinogenesis
  2. Zhu, Feng; Hu, Yinling
  3. Bioessays. 2018, Apr; 40(4): e1700131.
  1. 3.   Biophysical and biological evaluation of optimized stapled peptide inhibitors of the linear ubiquitin chain assembly complex (LUBAC)
  2. Aguilar Alonso, Francisco; Whiting, Amanda L.; Kim, Ye Joon; Bernal, Federico
  3. BIOORGANIC & MEDICINAL CHEMISTRY. 2018, Mar 15; 26(6): 1179-1188.
  1. 4.   Impaired Control of Epstein Barr Virus Infection in B-Cell Expansion with NF-kappa B and T-Cell Anergy Disease
  2. Arjunaraja, Swadhinya; Angelus, Pam; Su, Helen C.; Snow, Andrew L.
  3. FRONTIERS IN IMMUNOLOGY. 2018, Feb 8; 9
  1. 5.   Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa
  2. Meragelman, T. L.; Scudiero, D. A.; Davis, R. E.; Staudt, L. M.; McCloud, T. G.; Cardellina, J. H. 2nd.; Shoemaker, R. H.
  3. Journal of Natural Products. 2009, Mar 27; 72(3): 336-9.
  1. 6.   Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B
  2. Martin, A. G.; Trama, J.; Crighton, D.; Ryan, K. M.; Fearnhead, H. O.
  3. Aging-Us. 2009, Mar; 1(3): 335-349.
  1. 7.   Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappa B activation
  2. Iha, H.; Peloponese, J. M.; Verstrepen, L.; Zapart, G.; Ikeda, F.; Smith, C. D.; Starost, M. F.; Yedavalli, V.; Heyninck, K.; Dikic, I.; Beyaert, R.; Jeang, K. T.
  3. Embo Journal. 2008 27(4): 629-641.
  1. 8.   Ectodysplasin regulates the lymphotoxin-beta pathway for hair differentiation
  2. Cui, C. Y.; Hashimoto, T.; Grivennikov, S. I.; Piao, Y. L.; Nedospasov, S. A.; Schiessinger, D.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, Jun; 103(24): 9142-9147.
  1. 9.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 10.   Suppression of p65 phosphorylation coincides with inhibition of I kappa B alpha polyubiquitination and degradation
  2. Hu, J.; Haseebuddin, M.; Young, M.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2005, DEC; 44(4): 274-284.
  1. 11.   IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta(1-42), in a TNF-alpha-Activated microglia
  2. Iribarren, P.; Chen, K. Q.; Hu, J. Y.; Zhang, X.; Gong, W. H.; Wang, J. M.
  3. Journal of Immunology. 2005, NOV 1; 175(9): 6100-6106.
  1. 12.   Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
  2. Kong, D. H.; Park, E. J.; Stephen, A. G.; Calvani, M.; Cardellina, J. H.; Monks, A.; Fisher, R. J.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2005, OCT 1; 65(19): 9047-9055.
  1. 13.   Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex
  2. Youn, H. S.; Lee, J. Y.; Fitzgerald, K. A.; Young, H. A.; Akira, S.; Hwang, D. H.
  3. Journal of Immunology. 2005, SEP 1; 175(5): 3339-3346.
  1. 14.   Azidothymidine inhibits NF-kappa B and induces Epstein-Barr virus gene expression in Burkitt lymphoma
  2. Kurokawa, M.; Ghosh, S. K.; Ramos, J. C.; Mian, A. M.; Toomey, N. L.; Cabral, L.; Whitby, D.; Barber, G. N.; Dittmer, D. P.; Harrington, W. J.
  3. Blood. 2005, JUL 1; 106(1): 235-240.
  1. 15.   Coactivators and corepressors of NF-kappa B in I kappa Beta alpha gene promoter
  2. Gao, Z. G.; Chiao, P.; Zhang, X.; Zhang, X. H.; Lazar, M. A.; Seto, E.; Young, H. A.; Ye, J. P.
  3. Journal of Biological Chemistry. 2005, JUN 3; 280(22): 21091-21098.
  1. 16.   Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo
  2. Cataisson, C.; Pearson, A. J.; Torgerson, S.; Nedospasov, S. A.; Yuspa, S. H.
  3. Journal of Immunology. 2005, FEB 1; 174(3): 1686-1692.
  1. 17.   The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappa B activity in drug-sensitive MCF-7 cells
  2. Brantley, E.; Patel, V.; Stinson, S. F.; Trapani, V.; Hose, C. D.; Ciolino, H. P.; Yeh, G. C.; Gutkind, J. S.; Sausville, E. A.; Loaiza-Perez, A. I.
  3. Anti-Cancer Drugs. 2005, FEB; 16(2): 137-143.
  1. 18.   Co-operative functions between nuclear factors NF kappa B and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells
  2. Xiao, W. H.; Hodge, D. R.; Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Farrar, W. L.
  3. Prostate. 2004, DEC 1; 61(4): 354-370.
  1. 19.   BCL-3 and NF-kappa B p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages
  2. Wessells, J.; Baer, M.; Young, H. A.; Claudio, E.; Brown, K.; Siebenlist, U.; Johnson, P. F.
  3. Journal of Biological Chemistry. 2004, NOV 26; 279(48): 49995-50003.
  1. 20.   Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappa B activation and transformation in resistant JB6 cells
  2. Hu, J.; Nakano, H.; Sakurai, H.; Colburn, N. H.
  3. Carcinogenesis. 2004, OCT; 25(10): 1991-2003.
  1. 21.   NF-kappa B activates IL-6 expression through cooperation with c-Jun and IL6-AP1 site, but is independent of its IL6-NF kappa B regulatory site in autocrine human multiple myeloma cells
  2. Xiao, W. H.; Hodge, D. R.; Wang, L. H.; Yang, X. Y.; Zhang, X. H.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2004, OCT; 3(10): 1007-1017.
  1. 22.   Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: Role of p38 mitogen-activated protein kinase and NF-kappa B
  2. Matsuyama, W.; Wang, L. H.; Farrar, W. L.; Faure, M.; Yoshimura, T.
  3. Journal of Immunology. 2004 172(4): 2332-2340.
  1. 23.   High attenuation and immunogenicity of a simian immunodeficiency virus expressing a proteolysis-resistant inhibitor of NF-kappa B
  2. Quinto, I.; Puca, A.; Greenhouse, J.; Silvera, P.; Yalley-Ogunro, J.; Lewis, M. G.; Palmieri, C.; Trimboli, F.; Byrum, R.; Adelsberger, J.; Venzon, D.; Chen, X. N.; Scala, G.
  3. Journal of Biological Chemistry. 2004 279(3): 1720-1728.
  1. 24.   A novel cell-based system for the rapid quantitative evaluation of (anti)-inflammatory potential of test substances
  2. Kozlov, S. V.; Dobrovolskaia, M. A.; Rice, N. R.; Stewart, C. L.; Vogel, S. N.
  3. Journal of Immunological Methods. 2003 281(1-2): 51-63.
  1. 25.   The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation
  2. Hur, G. M.; Lewis, J.; Yang, Q. F.; Lin, Y.; Nakano, H.; Nedospasov, S.; Liu, Z. G.
  3. Genes & Development. 2003 17(7): 873-882.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel